Caredx Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Caredx Inc's ROI in the second quarter of 2026?
Caredx Inc achieved a return on average invested assets (ROI) of 31.1 % in its second quarter of 2026, this is above CDNA's average return on investment of -33.23%.
Caredx Inc invested over the 12 months ending in its second quarter of 2026 $357 million

ROI has improved compared to -2.45% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 37 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 837 to 2727.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-8.04 %	-15.75 %	-9.94 %	-4.15 %	-2.22 %
Y / Y Net Income Change TTM	129.12 %	-	-	-	-
Investment (TTM) in Millions	439	332	323	333	351
Return On Investment (TTM)	31.1 %	-2.45 %	-6.05 %	16.31 %	12.48 %
CDNA's Overall Ranking	# 2727	# 837	# 2111	# 416	# 522
Seq. Investment Change TTM	6.58 %	-5.13 %	-5.25 %	-4.01 %	-2.35 %
Seq. Net Income Change TTM	-	-	-	25.41 %	-7.53 %
Net Income (TTM) in Millions	111	-8	-21	61	48

CDNA Company Profile >> Back to CDNA Roi Comparisons >> See Annual CDNA Return On Investment

Return On Investment CDNA's Ranking
Within:	No.
Industry	# 3
Sector	# 38
Overall	# 2727

Return On Investment Statistics
High	Average	Low
29.42 %	-33.23 %	-163.04 %
(Jun 30 2026)		(Dec 31 2017)

Financial Statements
Caredx Inc's II. Quarter Investments	$ 439 Millions	CDNA's Balance sheet
Caredx Inc's II. Quarter Income	$ 111 Millions	Quarterly CDNA's Income Statement
CDNA's Income by Division		See CDNA's Income by Division

CDNA Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	323	402	389	467	489
Y / Y Investment Growth	-19.49 %	3.32 %	-16.76 %	-4.56 %	63.49 %
Net Income in Millions	-21	53	-190	-77	-31
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-6.6 %	13.08 %	-48.95 %	-16.4 %	-6.27 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CDNA's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CDNA's Competitors
Subscribers only: Roi for Caredx Inc's Suppliers
Subscribers only: Return On Investment for CDNA's Customers

Other Ratios
CDNA's Roa	CDNA's Inventory Turnover Ratio	CDNA's Growth Rates	CDNA's Dividend Statistics
	CDNA's Profitability Ratios	CDNA's Asset Turnover Ratio	CDNA's Dividend Growth
CDNA's Roe	CDNA's Valuation Ratios	CDNA's Financial Strength Ratios	CDNA's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Actinium Pharmaceuticals Inc	84.38 %
Exelixis Inc	82.05 %
Lensar Inc	75.31 %
Ironwood Pharmaceuticals inc	70.54 %
Oramed Pharmaceuticals Inc	68.90 %
Indivior Pharmaceuticals Inc	68.79 %
Rallybio Corporation	68.28 %
Fortress Biotech Inc	68.27 %
Earth Science Tech Inc	64.38 %
Meiragtx Holdings Plc	55.83 %
Elite Pharmaceuticals Inc	53.48 %
Idexx Laboratories Inc	51.80 %
Aurinia Pharmaceuticals Inc	50.35 %
Qhslab Inc	48.94 %
Q32 Bio Inc	47.43 %
Vaxart Inc	46.17 %
Liquidia Corporation	42.09 %
Tg Therapeutics Inc	39.26 %
Medpace Holdings Inc	35.54 %
Mettler toledo International Inc	34.41 %
Eli Lilly And Company	33.95 %
Acadia Pharmaceuticals Inc	31.05 %
Caredx Inc	29.42 %
Adma Biologics Inc	28.94 %
Protalix Biotherapeutics inc	25.72 %
Pro dex Inc	24.29 %
Innoviva Inc	23.33 %
Electromed Inc	23.18 %
Zevra Therapeutics Inc	22.90 %
Iradimed Corporation	22.57 %

Date modified: 2026-09-14T03:49:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.